Demographical study of acute lymphoblastic leukemia in Basrah

Mayada T. Abdul-Rahman; Nibras S. Al-Ammar; Hermann Kreyenberg

doi:10.53730/ijhs.v6nS5.9348

Authors

Mayada T. Abdul-Rahman PhD student at College of Medicine, University of Basrah, Basrah, Iraq
Nibras S. Al-Ammar
nibrasalammar@yahoo.com
Assistant Professor, College of Medicine, University of Basrah, Basrah, Iraq
Hermann Kreyenberg Dr. rer. nat., Goethe University Hospital, Frankfurt am Main, Stem Cell Transplantation Centre, MRD-Chimarism laboratory, Frankfurt, Germany

Keywords:

Acute lymphoblastic leukemia, T-ALL, B-ALL, residency, blasts, platelets, WBC, risk

Abstract

Background: Leukemia is a complex and biologically separate group of hematological cancer. Aim: Studying the association between demographical factors, hematological tests with type of ALL. Method: A cross-sectional study conducted during the period between 2020 and 2022, fifty children with acute lymphoblastic leukemia (ALL) and their ages ranged from ˂ 2 year - 15 years have been included. The patients diagnosed by specialist physicians based on clinical, histological and immunophenotypic procedures carried out locally at the Oncology Unit in Basrah Children Specialty Hospital. The cases of ALL distributed according to type of ALL, sex, age groups, and residency. Hematological parameters were studied in all those 50 patients before and after chemotherapy; Hb, platelets, WBC, peripheral blood blasts, and bone marrow blasts. Patient who showed WBC count equal to 50.000/ mm³, considered as standard-risk patient and who showed WBC count > 50.000/ mm³ considered as high-risk patient. Results: Out of 50 ALL patients, 45 were B-ALL and 5 were T-ALL. Males with B-ALL were 55.6% and females were 44.4% with no statistical differences. Males with T-ALL (80.0%) showed higher percentage than females (20.0%) with no statistical significant.

Downloads

Download data is not yet available.

References

Petridou E, Pourtsidis A, Trichopoulos D. Leukemias. In: Adami H, Hunter D, Trichopoulos D, editors. Textbook of Cancer Epidemiology. Oxford: Oxford University Press; 2008.

Wheatley K, Brookes CL, Howman AJ, Goldstone AH, Milligan DW, Prentice AG, et al. Prognostic factor analysis of the survival of elderly patients with AML in the MRC AML11 and LRF AML14 trials. British Journal of Haematology. 2009;145(5):598–605.

Feltbower RG, McNally RJQ, Kinsey SE, Lewis IJ, Picton SV, Proctor SJ, et al. Epidemiology of leukaemia and lymphoma in children and young adults from the north of England, 1990-2002. European Journal of Cancer. 2009;45(3):420–7

Xie Y, Davies SM, Xiang Y, Robison LL, Ross JA. Trends in leukemia incidence and survival in the United States (1973-1998). Cancer. 2003;97(9):2229–35.

Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DA, Gralnick HR et al. Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group. Br J Haematol 1976; 33: 451–458

Alvarnas JC, Brown PA, Aoun P, Ballen KK, Barta SK, Borate U et al. Acute lymphoid leukemia (version 2.2015). Natl Comprehens Cancer Netw 2015; 13: 1240–1279

Shah A, John BM, Sondhi V. Acute lymphoblastic leukemia with treatment—naive Fanconi anemia. Indian Pediatr 2013; 50: 508–510.

Sehgal S, Mujtaba S, Gupta D, Aggarwal R, Marwaha RK. High incidence of Epstein Barr virus infection in childhood acute lymphocytic leukemia: a preliminary study. Indian J Pathol Microbiol 2010; 53: 63–67.

Rowe JM. Prognostic factors in adult acute lymphoblastic leukaemia. Br J Haematol 2010; 150: 389–405.

Dores GM, Devesa SS, Curtis RE, Linet MS, Morton LM. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007. Blood. 2012;119(1):34–43.

Hilden JM. Analysis of prognostic factors of acute lymphoblastic leukemia in infants: report on CCG 1953 from the Children's Oncology Group. Blood. 2006;108(2):441–51

Schultz KR, Pullen DJ, Sather HN, et al. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children’s Cancer Group (CCG). Blood 2007;109: 926–935

Bispo J.A.B., Pinheiro P.S., Kobetz E.K.(2020). Epidemiology and Etiology of Leukemia and Lymphoma. Cold Spring Harb Perspect Med, 10(6) .

Alrudainy L.A., Salih H.M., Aldorky M. K.(2009). Incidence and Pattern of Childhood Leukaemia in Basrah, Iraq during 2003-2007. IJBC, 2 (1) ,11-18.

Hagopian A., Lafta R., Hassan J., Davis S., Mirick D., Takaro T. (2010). Trends in childhood leukemia in Basrah, Iraq, 1993-2007. Am J Public Health, 100(6),1081-1087.

Habib O.S., Al-Diab J.M., Mohsin A.A., Al-Elwe W.M., Hasan J.G., Al Haroon S.S., Al-Emara K.A. (2010). Experience and outcome of population-based cancer registration in Basrah-Southern Iraq in 2005-2008. Asian Pac J Cancer Prev. 11(4),1151-4.

Lyengar V., Shimanovsky A.( 2021). Leukemia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan–. PMID: 32809325.

V H J van der Velden, A Hochhaus, G Cazzaniga, T Szczepanski, J Gabert & J J M van Dongen. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects. Leukemia volume 17, pages1013–1034(2003).

Mous, R. Jasper, A. Luijks DMP. Mellink, CHM. Van Oers, MHJ. Kater AP. And Eldering, E. (2009). Immunoglobuline and T-cell receptor gene rearrangements as PCR-based targets are stable markers for monitoring minimal residual disease in acute lymphoblastic after stem cell transplantation. Leukemia 23, 1355-1358.

Hasan K.H. (2020) . Patterns of acute childhood leukemia . The Medical Journal of Basrah University, 38(2), 99-103

Chiaretti S., Vitale A., Cazzaniga G., Orlando S.M., Silvestri D., Fazi P., Valsecchi M.G., Elia L., Testi A.M., Mancini F., Conter V., te Kronnie G., Ferrara F., Di Raimondo F., Tedeschi A., Fioritoni G., Fabbiano F., Meloni G., Specchia G., Pizzolo G., Mandelli F., Guarini A., Basso G., Biondi A., Foà R.(2013). Clinico-biological features of 5202 patients with acute lymphoblastic leukemia enrolled in the Italian AIEOP and GIMEMA protocols and stratified in age cohorts. Haematologica, 98(11), 1702-10.

Orkin S.H., Nathan D.G., Ginsburg D., Look, A.T., Fisher D. E., Lux S. (2014). Nathan and Oski's Hematology and Oncology of Infancy and Childhood EBook. 8 th Elsevier Health Sciences, 19103-2899.

Khan M., Morshed A.A. , Ahmed T.U., Khan H.H., Ahmed A.F., Roy S., Kabir A.L. (2020). Platelet Indices As Markers For Remission In ALL During Induction of Remission: An Experience of 52 Cases. BANGLADESH J CHILD HEALTH , 44 (1) , 38

Badr Z.A., AL-Moosawi W.N., Ali S.K. (2021). Evaluation of VEGF-A in relation to childhood acute lymphoblastic leukemia (in Basrah, Iraq). Iraqi Natl J Med, Vol. 3(1).

Dai Q., Shi R., Zhang G., Yang H., Wang Y., Ye L., Peng L., Guo S., He J., Jiang Y.(2021). Combined use of peripheral blood blast count and platelet count during and after induction therapy to predict prognosis in children with acute lymphoblastic leukemia. Medicine(Baltimore), 100:15(e25548).

Dockerty JD, Draper G, Vincent T, Rowan SD, Bunch KJ. (2001). Case-control study of parental age, parity and socioeconomic level in relation to childhood cancers. International journal of epidemiology, 30(6):1428-37

Hastings, C. A., Torkildson, J. C. & Agrawal, A. K. Evaluation of the Child with a Suspected Malignancy. In: Hastings, C. A., Torkildson, J. C. & Agrawal, A. K. Handbook of Pediatric Hematology and Oncology: Children’s Hospital & Research Center Oakland. John Wiley & Sons, Ltd; 2012; p.122-132

Fasseh S. and Fazli R. 2014. Clinical presentation of acute leukemia. Physicians and Surgeons Pakistan, 24(7):472-476

Llano O.G. (2017). The complete blood count in the early diagnosis of acute leukemia in children .MedicinaUniversitaria, 18(73), 216-218.

Kong S.G., SeoJ. H., Jun S. E., Lee B. K., Lim Y.T. (2014). Childhood acute lymphoblastic leukemia with hyperleukocytosis at presentation. Blood research, 49(1), 29–35.

Gupta M., Devi P., Bishley A., Kataria S.P .,Sen R. (2021). Prevalence of early T-cell precursor acute lymphoblastic leukemia among immunophenotypically categorised acute T-cell lymphoblastic leukaemia cases. International Journal of Research in Medical Sciences, 9. 10, 18203/2320-6012.